Perspective Therapeutics, Inc.

NYSE:CATX

Pharmaceutical Preparations·SEATTLE, WA

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/10/25	→
10-Q	Q2 2025	6/30/25	8/13/25	→
10-Q	Q1 2025	3/31/25	5/12/25	→
10-K/A	FY 2024	12/31/24	3/28/25	→
10-K	FY 2024	12/31/24	3/26/25	→
10-Q	Q3 2024	9/30/24	11/12/24	→
↓

Earnings Releases (8-K)

16 shown

Filed	Period
2/2/26	Q1 FY2026	→
1/9/26	Q4 FY2026	→
11/10/25	Q4 FY2025	→
10/20/25	Q3 FY2025	→
8/13/25	Q3 FY2025	→
5/12/25	Q2 FY2025	→
↓

News (8-K)

64 shown

Filed	Type	Description
2/3/26	Agreement	Entry into a Material Definitive Agreement	→
1/14/26	Other	Other Events	→
1/12/26	Other	Other Events	→
12/1/25	Other	Other Events	→
11/6/25	Other	Other Events	→
11/3/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
2/3/26	424B5	424B5	→
2/2/26	FWP	FWP	→
3/26/25	S-8	S-8	→
3/26/25	POSASR	POSASR	→
8/14/24	S-8	S-8	→
8/13/24	424B5	424B5	→
↓

Filing History(1000 filings)

TypeDateAccessionPeriodSize

SCHEDULE 13G

Mar 10, 2026

0000919574-26-001548

—

26.7 KB

Mar 4, 2026

0001761768-26-0000034

Mar 2, 2026

5.6 KB

Mar 4, 2026

0001748615-26-0000024

Mar 2, 2026

5.6 KB

Mar 4, 2026

0001397331-26-0000024

Mar 2, 2026

5.6 KB

Mar 4, 2026

0001283301-26-0000084

Mar 2, 2026

5.6 KB

Mar 4, 2026

0001393007-26-0000024

Mar 2, 2026

5.6 KB

Mar 4, 2026

0001535289-26-0000034

Mar 2, 2026

5.8 KB

Mar 4, 2026

0001375410-26-0000034

Mar 2, 2026

5.8 KB

Mar 4, 2026

0001965071-26-0000024

Mar 2, 2026

5.8 KB

SCHEDULE 13G

Feb 12, 2026

0000895421-26-000048

—

8.0 KB

SCHEDULE 13G

Feb 9, 2026

0001831942-26-000003

—

15.5 KB

SCHEDULE 13G

Feb 6, 2026

0001193125-26-041315

—

131.3 KB

SCHEDULE 13G

Feb 5, 2026

0001441449-26-000003

—

7.4 KB

8-K

Feb 3, 2026

0001193125-26-0355088-K

Feb 2, 2026

18.1 MB

424B5

Feb 3, 2026

0001193125-26-034003424B5

—

979.7 KB

FWP

Feb 2, 2026

0001193125-26-032708FWP

—

184.1 KB

8-K

Feb 2, 2026

0001193125-26-0327068-K

Feb 2, 2026

17.3 MB

8-K

Jan 14, 2026

0001193125-26-0122598-K

Jan 14, 2026

10.5 MB

8-K

Jan 12, 2026

0001193125-26-0098468-K

Jan 12, 2026

279.0 KB

8-K

Jan 9, 2026

0001193125-26-0082778-K

Jan 9, 2026

268.5 KB

SCHEDULE 13G/A

Dec 5, 2025

0000315066-25-002958

—

11.4 KB

8-K

Dec 1, 2025

0001193125-25-3038958-K

Dec 1, 2025

23.6 MB

Nov 17, 2025

0001193125-25-2839534

Nov 13, 2025

5.2 KB

Nov 14, 2025

0001193125-25-2816264

Nov 12, 2025

5.2 KB

10-Q

Nov 10, 2025

0001193125-25-27432810-Q

Sep 30, 2025

9.0 MB

25 filings shown

Filed	Form	Description
4/16/25	DEFA14A	DEFA14A	→
4/16/25	DEF 14A	DEF 14A	→
4/18/24	DEFA14A	DEFA14A	→
4/18/24	DEF 14A	DEF 14A	→
4/8/24	PRE 14A	PRE 14A	→
8/22/23	DEFA14A	FORM DEFA14A	→
↓

Perspective Therapeutics, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(1000 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
3/4/26	4	4	→
3/4/26	4	4	→
3/4/26	4	4	→
3/4/26	4	4	→
3/4/26	4	4	→
3/4/26	4	4	→
↓

Filed	Form	Description
3/10/26	SCHEDULE 13G	SCHEDULE 13G	→
2/12/26	SCHEDULE 13G	SCHEDULE 13G	→
2/9/26	SCHEDULE 13G	SCHEDULE 13G	→
2/6/26	SCHEDULE 13G	SCHEDULE 13G	→
2/5/26	SCHEDULE 13G	SCHEDULE 13G	→
12/5/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
↓